Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X0PW
|
||||
Former ID |
DIB010802
|
||||
Drug Name |
Revamilast
|
||||
Synonyms |
GRC-4039; PDE 4 inhibitor (inflammation), Glenmark; Phosphodiesterase 4 inhibitor (inflammation), Glenmark; Revamilast (inflammation), Glenmark
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Asthma [ICD10:J45] | Phase 2 | [523630] | ||
Company |
Glenmark Pharmaceuticals Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H9Cl2F2N3O4
|
||||
Canonical SMILES |
c1(ccc(c2c1oc1c2cncc1)C(=O)Nc1c(c[n+](cc1Cl)[O-])Cl)OC(<br />F)F
|
||||
CAS Number |
CAS 893555-90-3
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Type IV phosphodiesterase | Target Info | Inhibitor | [550161] | |
CAMP-specific 3',5'-cyclic phosphodiesterase 4B | Target Info | Inhibitor | [550161] | ||
CAMP-specific 3',5'-cyclic phosphodiesterase 4A | Target Info | Inhibitor | [550161] | ||
NetPath Pathway | IL5 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
PathWhiz Pathway | Purine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.